{"id":"https://openalex.org/W2015346820","doi":"https://doi.org/10.1016/s0040-4039(01)01877-9","title":"A practical asymmetric synthesis of (R)-fluoxetine and its major metabolite (R)-norfluoxetine","display_name":"A practical asymmetric synthesis of (R)-fluoxetine and its major metabolite (R)-norfluoxetine","publication_year":2001,"publication_date":"2001-12-01","ids":{"openalex":"https://openalex.org/W2015346820","doi":"https://doi.org/10.1016/s0040-4039(01)01877-9","mag":"2015346820"},"language":"en","primary_location":{"id":"doi:10.1016/s0040-4039(01)01877-9","doi":"https://doi.org/10.1016/s0040-4039(01)01877-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0040-4039(01)01877-9","pdf_url":null,"source":{"id":"https://openalex.org/S133942674","display_name":"Tetrahedron Letters","issn_l":"0040-4039","issn":["0040-4039","1873-3581"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103430622","display_name":"James W. Hilborn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James W Hilborn","raw_affiliation_strings":["Sepracor Canada Ltd., 24 Ivey Lane, Windsor, N.S. Canada B0N 2T0"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sepracor Canada Ltd., 24 Ivey Lane, Windsor, N.S. Canada B0N 2T0","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102667584","display_name":"Zhi\u2010Hui Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zhi-Hui Lu","raw_affiliation_strings":["Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055295155","display_name":"Alex R. J\u00fcrgens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex R Jurgens","raw_affiliation_strings":["Sepracor Canada Ltd., 24 Ivey Lane, Windsor, N.S. Canada B0N 2T0"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sepracor Canada Ltd., 24 Ivey Lane, Windsor, N.S. Canada B0N 2T0","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073677677","display_name":"Q. Kevin Fang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Q.Kevin Fang","raw_affiliation_strings":["Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul Byers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Byers","raw_affiliation_strings":["Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023791089","display_name":"Stephen A. Wald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen A Wald","raw_affiliation_strings":["Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015397568","display_name":"Chris H. Senanayake","orcid":"https://orcid.org/0009-0009-3170-0687","observed_orcids":["https://orcid.org/0009-0009-3170-0687"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chris H Senanayake","raw_affiliation_strings":["Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sepracor, Inc., Chemical Process R&D, 111 Locke Dr., Marlborough, MA 01752, USA","institution_ids":["https://openalex.org/I4210122020"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015397568","https://openalex.org/A5102667584"],"corresponding_institution_ids":["https://openalex.org/I4210122020"],"apc_list":{"value":3610,"currency":"USD","value_usd":3610},"apc_paid":null,"fwci":4.6367,"has_fulltext":false,"cited_by_count":106,"citation_normalized_percentile":{"value":0.95687275,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"42","issue":"51","first_page":"8919","last_page":"8921"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.9115999937057495,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.9115999937057495,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13649","display_name":"Advanced Synthetic Organic Chemistry","score":0.025599999353289604,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11281","display_name":"Asymmetric Hydrogenation and Catalysis","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.8960000276565552},{"id":"https://openalex.org/keywords/norfluoxetine","display_name":"norfluoxetine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/asymmetric-synthesis","display_name":"asymmetric synthesis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cbs-reduction","display_name":"CBS reduction","score":0.9290000200271606},{"id":"https://openalex.org/keywords/hofmann-rearrangement","display_name":"Hofmann rearrangement","score":0.9380000233650208},{"id":"https://openalex.org/keywords/optical-purity","display_name":"optical purity","score":0.5139999985694885},{"id":"https://openalex.org/keywords/chromatography-free-synthesis","display_name":"chromatography-free synthesis","score":0.8619999885559082},{"id":"https://openalex.org/keywords/antidepressant-metabolites","display_name":"antidepressant metabolites","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9549123048782349},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.7562286853790283},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.7556070685386658},{"id":"https://openalex.org/C2777699559","wikidata":"https://www.wikidata.org/wiki/Q425046","display_name":"Tartrate","level":2,"score":0.5719206929206848},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.47930923104286194},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4534277617931366},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4410635232925415},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3362376093864441},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2734072804450989},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1006474494934082},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0040-4039(01)01877-9","doi":"https://doi.org/10.1016/s0040-4039(01)01877-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0040-4039(01)01877-9","pdf_url":null,"source":{"id":"https://openalex.org/S133942674","display_name":"Tetrahedron Letters","issn_l":"0040-4039","issn":["0040-4039","1873-3581"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1519784149","https://openalex.org/W1967105703","https://openalex.org/W1967812247","https://openalex.org/W1975638493","https://openalex.org/W2001665011","https://openalex.org/W2005786571","https://openalex.org/W2016624695","https://openalex.org/W2017870692","https://openalex.org/W2018230108","https://openalex.org/W2031942559","https://openalex.org/W2034802512","https://openalex.org/W2036361210","https://openalex.org/W2056437891","https://openalex.org/W2057755142","https://openalex.org/W2071047685","https://openalex.org/W2089603011","https://openalex.org/W2142137123","https://openalex.org/W2158683204","https://openalex.org/W2950383949","https://openalex.org/W2950851740","https://openalex.org/W2952448982"],"related_works":["https://openalex.org/W2001665011","https://openalex.org/W2037488976","https://openalex.org/W2369731820","https://openalex.org/W2051785174","https://openalex.org/W2367759485","https://openalex.org/W2018271495","https://openalex.org/W2034802512","https://openalex.org/W2036361210","https://openalex.org/W1967105703","https://openalex.org/W2033185531"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}